Pharmacokinetic problems in clinical practice - role of drug transporters

被引:6
作者
Rosskopf, D. [1 ]
Kroemer, H. K. [1 ]
Siegmund, W. [2 ]
机构
[1] Ernst Moritz Arndt Univ Greifswald, Inst Pharmakol, Abt Allgemeine Pharmakol, D-17485 Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Inst Pharmakol, Klin Pharmakol Abt, D-17485 Greifswald, Germany
关键词
drug interactions; drug transport; drug metabolism; CYP enzymes; ABC-transporter; SLCO1B1; ST-JOHNS-WORT; INTESTINAL P-GLYCOPROTEIN; ORAL BIOAVAILABILITY; GRAPEFRUIT JUICE; TALINOLOL; DIGOXIN; DISPOSITION; INDUCTION; ABC; INHIBITION;
D O I
10.1055/s-0028-1124005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:345 / 356
页数:12
相关论文
共 34 条
  • [1] The safety of statins in clinical practice
    Armitage, Jane
    [J]. LANCET, 2007, 370 (9601) : 1781 - 1790
  • [2] BAILEY DG, 1989, CLIN INVEST MED, V12, P357
  • [3] Herbal medicine in the United States: Review of efficacy, safety, and regulation - Grand rounds at University of California, San Francisco Medical Center
    Bent, Stephen
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (06) : 854 - 859
  • [4] Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms
    Bernsdorf, A
    Giessmann, T
    Modess, C
    Wegner, D
    Igelbrink, S
    Hecker, U
    Haenisch, S
    Cascorbi, I
    Terhaag, B
    Siegmund, W
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (04) : 440 - 450
  • [5] ABC of oral bioavailability: transporters as gatekeepers in the gut
    Dietrich, CG
    Geier, A
    Elferink, RPJO
    [J]. GUT, 2003, 52 (12) : 1788 - 1795
  • [6] P-glycoprotein-mediated intestinal and biliary digoxin transport in humans
    Drescher, S
    Glaeser, H
    Mürdter, T
    Hitzl, M
    Eichelbaum, M
    Fromm, MF
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (03) : 223 - 231
  • [7] Coordinate induction of both cytochrome P4503A and MDRI by St John's wort in healthy subjects
    Dresser, GK
    Schwarz, UI
    Wilkinson, GR
    Kim, RB
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (01) : 41 - 50
  • [8] St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
    Dürr, D
    Stieger, B
    Kullak-Ublick, GA
    Rentsch, KM
    Steinert, HC
    Meier, PJ
    Fattinger, K
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) : 598 - 604
  • [9] The effect of rifampin treatment on intestinal expression of human MRP transporters
    Fromm, MF
    Kauffmann, HM
    Fritz, P
    Burk, O
    Kroemer, HK
    Warzok, RW
    Eichelbaum, M
    Siegmund, W
    Schrenk, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) : 1575 - 1580
  • [10] Inhibition of P-glycoprotein-mediated drug transport - A unifying mechanism to explain the interaction between digoxin and quinidine
    Fromm, MF
    Kim, RB
    Stein, CM
    Wilkinson, GR
    Roden, DM
    [J]. CIRCULATION, 1999, 99 (04) : 552 - 557